Amphastar Pharmaceuticals (AMPH) Inventory Average (2014 - 2026)

Amphastar Pharmaceuticals has reported Inventory Average for 13 years, with the latest figure at $175.1 million in Q2 2026.

• On a quarterly basis, Inventory Average fell 7.19% year-over-year to $175.1 million in Q2 2026; TTM through Jun 2026 was $175.1 million, a 7.19% decrease from a year earlier, with the FY2025 full-year figure at $165.3 million, up 27.37% from the prior year.
• Inventory Average was $175.1 million for Q2 2026 at Amphastar Pharmaceuticals, up from $173.5 million in the prior quarter.
• The five-year high for Inventory Average was $188.8 million in Q3 2025, with the low at $94.0 million in Q1 2022.
• Average Inventory Average over 5 years is $133.0 million, with a median of $114.8 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Inventory Average soared 58.55% in 2025, then declined 7.19% in 2026.
• Over 5 years, Inventory Average stood at $103.4 million in 2022, then advanced by 4.34% to $107.9 million in 2023, then jumped by 31.62% to $142.0 million in 2024, then increased by 27.73% to $181.4 million in 2025, then fell by 3.51% to $175.1 million in 2026.
• The last three Inventory Average figures came in at $175.1 million (Q2 2026), $173.5 million (Q1 2026), and $181.4 million (Q4 2025), per Business Quant data.